398 related articles for article (PubMed ID: 2013383)
1. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F; Slametschka D; Gregor M; Weber P
Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
Lo SK; Fleming KA; Chapman RW
Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
[TBL] [Abstract][Full Text] [Related]
5. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
[TBL] [Abstract][Full Text] [Related]
6. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses.
Duerr RH; Targan SR; Landers CJ; Sutherland LR; Shanahan F
Gastroenterology; 1991 Jun; 100(6):1590-6. PubMed ID: 2019365
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
10. [Anticytoplasmic auto-antibodies of polynuclear neutrophils: a common biologic marker in hemorrhagic rectocolitis and primary sclerosing cholangitis].
Jacquot S
Gastroenterol Clin Biol; 1991; 15(12):990-1. PubMed ID: 1783264
[No Abstract] [Full Text] [Related]
11. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
Bansi DS; Lo S; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
Jahn HU; Zeitz M
Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
[No Abstract] [Full Text] [Related]
14. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
[TBL] [Abstract][Full Text] [Related]
15. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis.
Klein R; Eisenburg J; Weber P; Seibold F; Berg PA
Hepatology; 1991 Dec; 14(6):1147-52. PubMed ID: 1720413
[TBL] [Abstract][Full Text] [Related]
16. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
17. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman RW; Cottone M; Selby WS; Shepherd HA; Sherlock S; Jewell DP
Gut; 1986 Jan; 27(1):86-91. PubMed ID: 3485067
[TBL] [Abstract][Full Text] [Related]
18. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.
Hardarson S; Labrecque DR; Mitros FA; Neil GA; Goeken JA
Am J Clin Pathol; 1993 Mar; 99(3):277-81. PubMed ID: 8447289
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Zauli D; Baffoni L; Cassani F; Fusconi M; Lenzi M; Ballardini G; Luigi M; Bianchi FB; Schrumpf E
Gastroenterology; 1992 Mar; 102(3):1088-90. PubMed ID: 1537507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
